IGF2-H19 Locus Expression Profile and Biomarker Potential in Oral Cancer

Area of Science:

• Genetics
• Molecular Biology
• Oncology

Background:

• The Insulin-like Growth Factor 2 - الهيبوكسي القابل للتحلل 19 (IGF2-H19) locus is crucial for development and growth.
• Deregulation of the IGF2-H19 locus is linked to various cancers, but its role in oral cancer remains unclear.

Purpose of the Study:

• To investigate the expression of IGF2, H19, and hsa-miR-675-5p in oral cancer.
• To evaluate their potential as diagnostic biomarkers for oral cancer.

Main Methods:

• Analysis of IGF2 and H19 expression in oral cancer cell lines (SCC-25, SCC-15) and normal keratinocytes (HaCaT).
• Quantitative analysis of IGF2, H19, and hsa-miR-675-5p in tumor and adjacent non-cancerous tissues from 55 oral cancer patients.
• Assessment of the molecules' ability to discriminate between cancerous and non-cancerous tissues.

Main Results:

• IGF2 and H19 expression were elevated in oral cancer cell lines compared to controls.
• Expression of the IGF2-H19 locus and hsa-miR-675-5p was significantly lower in oral cancer tissues than in adjacent non-cancerous tissues.
• Individually, IGF2, H19, and hsa-miR-675-5p showed moderate diagnostic ability; combined analysis improved discrimination.

Conclusions:

• The IGF2-H19 locus and hsa-miR-675-5p show promise as molecular biomarkers for differentiating oral cancer from non-cancerous tissues.
• These molecules do not appear to hold prognostic value for oral cancer.